Search Results

• • 3 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Clinical efficacy of nivolumab is associated with tertiary lymphoid structures in surgically resected primary tumors of recurrent gastric cancer.

  Authors:Takuya Mori, Hiroaki Tanaka, Sota Deguchi, Yoshihito Yamakoshi, Yuichiro Miki, Mami Yoshii, et al.From:PLoS ONE (Vol. 17, Issue 1) Peer-Reviewed

  Jan. 7, 20224,533 words Report 1330LNivolumab, an immune checkpoint blocker, has been approved for advanced gastric cancer (GC), but predictive factors of nivolumab's efficacy in patients with GC, especially immune cells such as tissue-resident memory T...

• The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients.

  Authors:Atsushi Sugimoto, Tomohisa Okuno, Gen Tsujio, Tomohiro Sera, Yurie Yamamoto, Koji Maruo, et al.From:PLoS ONE (Vol. 16, Issue 7) Peer-Reviewed

  July 13, 20213,484 words Report 1260LBackground Gastric cancer (GC) patients frequently develop peritoneal metastasis. Recently, it has been reported that peritoneal mesothelial cells (PMCs) activated by GC cells acquire a migratory capacity and promote...

• Correction: Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer

  Authors:Shingo Togano, Masakazu Yashiro, Yuichiro Miki, Yurie Yamamoto, Tomohiro Sera, Yukako Kushitani, et al.From:PLoS ONE (Vol. 15, Issue 5) Peer-Reviewed

  May 26, 2020188 words Brief article, Corre... 760LAuthor(s): Shingo Togano, Masakazu Yashiro, Yuichiro Miki, Yurie Yamamoto, Tomohiro Sera, Yukako Kushitani, Atsushi Sugimoto, Shuhei Kushiyama, Sadaaki Nishimura, Kenji Kuroda, Tomohisa Okuno, Mami Yoshii, Tatsuro...